Teladoc Health (TDOC) Return on Sales (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Sales retreated to 0.0% in Q1 2026, from 0.0% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.0% in Q4 2025 to a low of 0.12% in Q1 2022.
• A 5-year average of 0.01% and a median of 0.0% in 2026 frame the typical range for Return on Sales.
• Across the five-year window, Return on Sales slipped 11 bps in 2022 and gained 12 bps in 2023, its largest moves.
• Tracing TDOC's Return on Sales over 5 years: stood at 0.06% in 2022, then surged by 99 bps to 0.0% in 2023, then plunged by 73 bps to 0.0% in 2024, then soared by 48 bps to 0.0% in 2025, then sank by 166 bps to 0.0% in 2026.
• Business Quant data shows TDOC's Return on Sales at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.